It is a chemicals private limited company based in Agra, Uttar Pradesh, India, established in 2015.
2015 | Agra, Uttar Pradesh, India | ActiveGenomics Formulations Private Limited, a active private limited company, was established on 19 October 2015 in Agra, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24233UP2015PTC073965. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a active non-compliant status. Its leadership includes Raja Pujari (Director), Vijay Laxmi (Director), Prasanna Shastry Kammaradi Srinivasa Shastry (Director). Past directors included Prasanna Shastry Kammaradi Srinivasa Shastry, Yajnanarayana Eachalasara Nagabhushana Udupa, Vinay Suresh. Its latest AGM occurred on 01 December 2016, with the balance sheet filed on 31 March 2016. It is based at Shop No. 509, 5Th Floor, Maruti Plaza, Sanjay Place,, Agra, Uttar Pradesh, 282002.
U24233UP2015PTC073965
073965
19 October 2015
₹1.00 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Genomics Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raja Pujari | Director | 19 Oct 2015 | Current |
| Vijay Laxmi | Director | 19 Oct 2015 | Current |
| Prasanna Shastry Kammaradi Srinivasa Shastry | Director | 21 Mar 2016 | Current |
| Yajnanarayana Eachalasara Nagabhushana Udupa | Director | 21 Mar 2016 | Current |
| Vinay Suresh | Additional Director | 15 Dec 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Sep 2017 | Past |
| Pramod Abcsdd | Director | 27 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Genomics Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2016, Genomics Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Genomics Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Genomics Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomics Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vinay Suresh was appointed as a Additional Director was appointed as a Additional Director on 15 Dec 2016 & has been associated with this company since 8 years 11 months . was documented.
Genomics Formulations Private Limited last Annual general meeting of members was held on 01 Dec 2016 as per latest MCA records. was recorded as a recent event.
Progress on Genomics Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Kanpur. was documented.
Prasanna Shastry Kammaradi Srinivasa Shastry was appointed as a Director was appointed as a Director on 21 Mar 2016 & has been associated with this company since 9 years 8 months . was recorded as a recent event.
The activity Yajnanarayana Eachalasara Nagabhushana Udupa was appointed as a Director was appointed as a Director on 21 Mar 2016 & has been associated with this company since 9 years 8 months . was completed.
Progress on Raja Pujari was appointed as a Director was appointed as a Director on 19 Oct 2015 & has been associated with this company since 10 years 1 month . was documented.
The CIN of Genomics Formulations Private Limited is U24233UP2015PTC073965.
Genomics Formulations Private Limited is headquartered at Shop No. 509, 5Th Floor, Maruti Plaza, Sanjay Place,, Agra, Uttar Pradesh, 282002.
Genomics Formulations Private Limited was incorporated on 19 October 2015.
The current directors of Genomics Formulations Private Limited are
The primary industry of Genomics Formulations Private Limited is Chemicals.
Genomics Formulations Private Limited is unlisted.
The authorized capital of Genomics Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Genomics Formulations Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX